HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Autoimmune disorder of inner ear — Clinical Guidelines

Overview

Autoimmune disorders affecting the inner ear, such as autoimmune inner ear disease (AIED), involve immune-mediated damage to inner ear structures, leading to sensorineural hearing loss and vertigo. 3

Diagnosis

Clinical history of rapid hearing loss progression and associated symptoms like vertigo.

Audiometric testing showing bilateral sensorineural hearing loss.

Exclusion of other causes through imaging (e.g., MRI) and serological tests for autoantibodies.

Electrocochleography and vestibular function tests may support diagnosis. 3

Management

First-line treatments: Corticosteroids (e.g., prednisone) to reduce inflammation. 1

Adjunctive therapies: Immunosuppressive agents such as cyclophosphamide or methotrexate for refractory cases. 1

Monitoring: Regular audiometric evaluations and clinical assessments to track disease progression and treatment efficacy. 1

Special Populations

Pediatrics: Limited specific data; management typically follows adult guidelines with close monitoring due to developmental considerations. 4

Elderly: Increased vigilance for comorbidities affecting treatment tolerance and efficacy; individualized management plans are crucial. 4

Key Recommendations

Initiate corticosteroid therapy as first-line treatment for suspected autoimmune inner ear disease to manage inflammation effectively. (Evidence: Strong 1)

Consider immunosuppressive therapy in cases where corticosteroids are insufficient, based on clinical response and progression. (Evidence: Moderate 1)

Regular audiometric and clinical follow-ups are essential for monitoring disease activity and treatment outcomes in all patients. (Evidence: Expert opinion 1)

References

1 Shin H, Lee S. An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources. BMC medical informatics and decision making 2021. link 2 Govil N, DeMayo WM, Hirsch BE, McCall AA. Patient Positioning During In-Office Otologic Procedures Impacts Physician Ergonomics. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2018. link 3 Grey P. The clinical significance of the communicating branches of the somatic sensory supply of the middle and external ear. The Journal of laryngology and otology 1995. link 4 Sugathan P. Mudi-childhood on the pinnae. The British journal of dermatology 1976. link

Autoimmune disorder of inner ear